Anticoagulant Beneficial For COVID-19 Patients, Study Finds

Researchers have shown that a member of the anticoagulant group of drugs not only has a beneficial effect on survival of COVID-19 patients, but also influences the duration of active infection with the SARS-CoV-2 coronavirus.